M James Mock's most recent trade in Moderna Inc was a trade of 63,478 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 28, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 63,478 | 63,478 | - | - | Stock Option (Right to Buy) | |
Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 39,606 | 39,606 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 329 | 15,034 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 329 | 2,630 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.09 per share. | 28 Feb 2025 | 160 | 14,874 (0%) | 0% | 31.1 | 4,974 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 3,094 | 9,283 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 3,094 | 15,517 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 27 Feb 2025 | 1,496 | 14,021 (0%) | 0% | 33.6 | 50,236 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,326 | 13,065 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,326 | 0 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,326 | 0 | - | - | Performance Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,326 | 15,347 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 27 Feb 2025 | 642 | 14,705 (0%) | 0% | 33.6 | 21,558 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 27 Feb 2025 | 642 | 12,423 (0%) | 0% | 33.6 | 21,558 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 1,453 | 12,519 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 1,453 | 10,169 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. | 03 Jan 2025 | 780 | 11,739 (0%) | 0% | 42 | 32,760 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 188,761 | 188,761 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 42.79 per share. | 27 Nov 2024 | 1,420 | 11,066 (0%) | 0% | 42.8 | 60,761 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 1,326 | 1,326 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 1,326 | 1,326 | - | - | Performance Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 1,326 | 12,486 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 1,326 | 10,831 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 329 | 2,959 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 329 | 11,160 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 1,453 | 11,622 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 1,453 | 10,220 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.12 per share. | 04 Oct 2024 | 715 | 9,505 (0%) | 0% | 60.1 | 42,986 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2024 | 329 | 3,288 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2024 | 329 | 8,929 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 78.02 per share. | 28 Aug 2024 | 162 | 8,767 (0%) | 0% | 78.0 | 12,640 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 1,326 | 8,595 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 1,326 | 2,652 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 1,326 | 2,652 | - | - | Performance Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 1,326 | 9,921 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 79.40 per share. | 27 Aug 2024 | 1,321 | 8,600 (0%) | 0% | 79.4 | 104,881 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2024 | 1,452 | 13,075 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2024 | 1,452 | 7,958 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 118.24 per share. | 05 Jul 2024 | 689 | 7,269 (0%) | 0% | 118.2 | 81,465 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 5,304 | 5,304 | - | - | Performance Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 1,326 | 3,978 | - | - | Performance Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 1,326 | 7,197 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 140.72 per share. | 31 May 2024 | 691 | 6,506 (0%) | 0% | 140.7 | 97,237 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 328 | 6,054 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 328 | 3,617 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 144.50 per share. | 28 May 2024 | 183 | 5,871 (0%) | 0% | 144.5 | 26,444 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 1,326 | 6,374 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 1,326 | 3,978 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 162.47 per share. | 24 May 2024 | 648 | 5,726 (0%) | 0% | 162.5 | 105,283 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2024 | 1,453 | 5,753 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2024 | 1,453 | 14,527 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 101.93 per share. | 05 Apr 2024 | 705 | 5,048 (0%) | 0% | 101.9 | 71,859 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 1,315 | 4,947 (0%) | 0% | - | Common Stock | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 1,315 | 3,945 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 94.57 per share. | 28 Feb 2024 | 647 | 4,300 (0%) | 0% | 94.6 | 61,188 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 60,216 | 60,216 | - | - | Stock Option (Right to Buy) | |
Moderna Inc | James Mock M | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 23,635 | 23,635 | - | - | Stock Option (Right to Buy) | |
Moderna Inc | M James Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 12,377 | 12,377 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 5,304 | 5,304 | - | - | Restricted Stock Units | |
Moderna Inc | James Mock M | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 1,452 | 15,980 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 1,452 | 4,404 (0%) | 0% | - | Common Stock | |
Moderna Inc | Mock James M | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 109.76 per share. | 05 Jan 2024 | 772 | 3,632 (0%) | 0% | 109.8 | 84,731 | Common Stock |
Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 20,040 | 20,040 | - | - | Stock Option (Right to Buy) | |
Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 5,260 | 5,260 | - | - | Restricted Stock Units | |
Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2022 | 43,876 | 43,876 | - | - | Stock Option (Right to Buy) | |
Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2022 | 23,242 | 23,242 | - | - | Restricted Stock Units | |
Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 145.78 per share. | 24 Jun 2022 | 2,290 | 28,240 (0%) | 0% | 145.8 | 333,836 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 144.90 per share. | 24 Jun 2022 | 2,072 | 30,530 (0%) | 0% | 144.9 | 300,233 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 146.34 per share. | 24 Jun 2022 | 663 | 27,577 (0%) | 0% | 146.3 | 97,023 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 13,054 | 39,048 (0%) | 0% | 0 | Common Stock | |
Revvity Inc. | James M Mock | Please See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 9,771 | 9,771 | - | - | NQ Stock Option (right to buy) | |
Revvity Inc. | James M Mock | Please See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 182.95 per share. | 04 Feb 2022 | 4,998 | 34,050 (0%) | 0% | 182.9 | 914,384 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 2,750 | 25,994 (0%) | 0% | 0 | Common Stock | |
Revvity Inc. | James M Mock | Please See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 182.95 per share. | 04 Feb 2022 | 1,448 | 32,602 (0%) | 0% | 183.0 | 264,912 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 183.93 per share. | 20 Sep 2021 | 1,803 | 26,221 (0%) | 0% | 183.9 | 331,626 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 185.30 per share. | 20 Sep 2021 | 1,377 | 24,844 (0%) | 0% | 185.3 | 255,158 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 183.18 per share. | 20 Sep 2021 | 1,300 | 28,024 (0%) | 0% | 183.2 | 238,134 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 187.17 per share. | 20 Sep 2021 | 1,100 | 23,344 (0%) | 0% | 187.2 | 205,887 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 186.09 per share. | 20 Sep 2021 | 400 | 24,444 (0%) | 0% | 186.1 | 74,436 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 187.99 per share. | 20 Sep 2021 | 100 | 23,244 (0%) | 0% | 188.0 | 18,799 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.50 per share. | 17 May 2021 | 4,005 | 29,324 (0%) | 0% | 143.5 | 574,718 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.99 per share. | 06 Apr 2021 | 543 | 33,329 (0%) | 0% | 131.0 | 71,128 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 11,125 | 11,125 | - | - | NQ Stock Option (right to buy) | |
Revvity Inc. | James M Mock | Please See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 2,678 | 33,872 (0%) | 0% | 0 | Common Stock | |
Revvity Inc. | James M Mock | Please See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 8,560 | 35,778 (0%) | 0% | 0 | Common Stock | |
Revvity Inc. | James M Mock | Please See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.07 per share. | 01 Feb 2021 | 2,810 | 32,968 (0%) | 0% | 147.1 | 413,267 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.07 per share. | 01 Feb 2021 | 1,774 | 31,194 (0%) | 0% | 147.1 | 260,902 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 124.58 per share. | 02 Oct 2020 | 4,423 | 27,318 (0%) | 0% | 124.6 | 551,017 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 123.69 per share. | 02 Oct 2020 | 1,100 | 31,741 (0%) | 0% | 123.7 | 136,059 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 125.08 per share. | 02 Oct 2020 | 100 | 27,218 (0%) | 0% | 125.1 | 12,508 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.97 per share. | 15 May 2020 | 2,950 | 32,841 (0%) | 0% | 92.0 | 271,312 | Common Stock |
Revvity Inc. | James M Mock | Please See Remarks | Grant, award, or other acquisition of securities at price $ 75.13 per share. | 06 Apr 2020 | 1,124 | 35,791 (0%) | 0% | 75.1 | 84,446 | Common Stock |